The Silicon Review
The pharmaceutical manufacturing industry, in the past few decades, is experiencing a fast paced change in a competitive and regulated environment. As pharmaceutical companies focus on developing new drugs and enhancing their manufacturing processes, the complexities of their businesses keep growing through their entire supply chain. This has burdened them with the responsibility of managing the quality of their products along with the challenge to remain compliant on multiple regulatory levels. Therefore pharmaceutical companies outsource their non-core activities, manufacturing in particular, in order to reduce costs and focus their energy on improving their value chain.
Contract manufacturing organizations have become a critical element in pharmaceutical company operations and now have a long part to play in the growth of the pharmaceutical industry. Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India) is one such company that is internationally recognized and WHO-GMP certified contract manufacturing pharmaceutical company of India. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe.
In a span of few years, the organization has become the preferred business partner for all Pharma Companies of India for Contract Manufacturing and supplying more than 10% of India’s total domestic consumption of pharmaceutical formulations. Akums has the best of dedicated pharmaceutical personnel and standardized practices, and has been successful in attaining national and international accreditations and building trust on Efficacy, Safety & Quality. The organization is certified with WHO-GMP, ISO 9001:2008, ISO 14001:2004 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others.
Akums: The one stop destination for pharma companies
Akums is India’s single largest Contract Research and Manufacturing (CRAMS) organization responsible for manufacturing approximately 11-12 % of all drugs consumed in the country. The organization offers the following comprehensive range of services starting from formulation development to market launch all en suite.
Akums’ eleven state of the art facilities are equipped to produce all modern dosage forms — tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups and suspensions, injections, eye/ear drops, ointments, creams, gels, lotions, ayurveda and herbal preparations, nutraceutical and cosmetic preparations and many more. Akums offers significant manufacturing capacities, offering 162 million tablets, 23 million hard gelatin capsules, 1 million ampoules, 25 million 3-piece eye/nasal drops, and 0.315 million liquid orals. Akums has emerged as an integrated solution provider for companies seeking specific development and business goals. Along with its core service offering, the company offers advanced solutions for formulation development and testing.
Commitment to excellence
Akums has dedicatedly striven towards achieving highest standards of quality at par with international benchmarks. The company’s consistent efforts have received various awards and recognitions by renowned authorities and regulatory bodies in the Pharmaceuticals Industry. As a young yet successful player in the pharmaceutical segment, the Pharmaceutical giant has been consistent and committed in maintaining high level of quality in manufacturing medicines. With the determination to achieve and heart for success, the company’s talented team lets its work speak for itself. Such ambitious intentions have got the organization some prestigious recognitions that make the company proud.
“In a crowded and competitive business milieu, with a continuous endeavor to create a win – win situation, Akums is progressing, hand in hand, with all the business partners. We house brands for big multinationals & big Pharma companies. At Akums, we strongly believe that the essence of business is to create customer delight and growth and profits shall follow”, the company said. Akums’ experience, market knowledge, pharmaceutical segment knowledge and technical expertise enable it to deliver the right solution to the clients in an extension to its own business.
The roadmap to success
With manufacturing expertise along with innovation & quality approach, Akums has marked its presence in the Indian & global pharmaceutical space with its export subsidiary UNOSOURCE PHARMA LTD. It exports its formulations to various global markets and has also filed substantial numbers of dossiers as per CTD, ACTD and guidelines of the MOH of various countries.
The company has plans in pipeline to create joint ventures in various countries and to set up manufacturing units and packaging units for its semi-finished products. Akums endeavors to export its unique formulations around the globe and redesign global healthcare towards a happier world.
Knowing the thought leaders
Mr. Sanjeev Jain, Whole Time Director
Mr. Sanjeev Jain has approximately 33 years of experience in the field of sales and marketing of pharmaceuticals. He has been awarded order of Merit for Management and honored as Samaj Shree for his services rendered to the public. He is the Honorary Secretary of Federation of Pharmaceutical Enterprise (FOPE). He is the Promoter Director of the Company.
Mr. D.C. Jain, Founder
Mr. D.C Jain, B. Com., LL.B., F.C.S., is an active promoter of Akums Drugs & Pharmaceuticals Ltd. With an experience of more than five decades, he has been the President of the Institute of Company Secretaries of India.
Mr. Sandeep Jain, Whole Time Director
Mr. Sandeep Jain is a founder Director of Akums Pharmaceuticals Limited and has approximately 33 years of experience. Mr. Jain is actively associated with many trade and commercial organizations. He has been a sitting member of the managing committee of the PHDCCI, Vice President of Bhiwadi Manufacturers Association, CHAIRMAN CII State Council, Uttrakhand, and Chairman of Association of Pharmaceutical Manufacturers.
The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...
Singapore’s open economy depends heavily on tourism and business. But its vibrant but small economy has been hurting as the circumstances due to...
2020 has been an unforgettable year for many of us. The ongoing Covid crisis has reminded people that it is very important to have an uninterrupted an...
Department of Telecommunications (DoT) is all set to announce the new schedule for 5G trials. The Dot made this decision after being pulled by the par...